Key stats
About PHARMACEUTICAL ETF
Home page
Inception date
Jan 9, 2021
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
E Fund Management Co., Ltd.
ISIN
CNE1000028S3
Tightly track the target index, pursue the minimization of tracking deviation and tracking err.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.75%
Health Technology92.62%
Health Services4.93%
Process Industries2.20%
Commercial Services0.00%
Producer Manufacturing0.00%
Non-Energy Minerals0.00%
Electronic Technology0.00%
Consumer Durables0.00%
Distribution Services0.00%
Bonds, Cash & Other0.25%
Cash0.25%
Miscellaneous0.00%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
512010 invests in stocks. The fund's major sectors are Health Technology, with 92.62% stocks, and Health Services, with 4.93% of the basket. The assets are mostly located in the Asia region.
512010 top holdings are Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A, occupying 16.35% and 12.35% of the portfolio correspondingly.
512010 assets under management is 21.03 B CNY. It's fallen 4.36% over the last month.
512010 fund flows account for 2.49 B CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 512010 doesn't pay dividends to its holders.
512010 shares are issued by E Fund Management Co., Ltd. under the brand E Fund. The ETF was launched on Jan 9, 2021, and its management style is Passive.
512010 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
512010 follows the CSI 300 Medical and Health Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
512010 invests in stocks.
512010 price has risen by 8.29% over the last month, and its yearly performance shows a 5.62% increase. See more dynamics on 512010 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 6.76% over the last month, showed a 4.93% increase in three-month performance and has increased by 8.23% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 6.76% over the last month, showed a 4.93% increase in three-month performance and has increased by 8.23% in a year.
512010 trades at a premium (0.05%) meaning the ETF is trading at a higher price than the calculated NAV.